Immunology and Microbiology
Immunology
67%
Immunoglobulin E
65%
Immunotherapy
65%
Immunoglobulin E Antibody
61%
Trastuzumab
61%
Allergen
55%
B Cell
52%
Adeno Associated Virus
50%
HER2/neu
50%
Antibody Response
50%
Mimotope
50%
Effector Cell
48%
Tumor Cell
41%
Monoclonal Antibody
38%
Bagg Albino Mouse
36%
Tumor Antigen
35%
Sensitization
32%
Immunocompetent Cell
31%
Phagocytosis
31%
Antibody Production
31%
Anaphylaxis
27%
Antibody-Dependent Cell-Mediated Cytotoxicity
26%
Severe Acute Respiratory Syndrome Coronavirus 2
25%
C57BL 6 Mouse
25%
Antibody Engineering
25%
Carcinoembryonic Antigen
25%
Lipocalin
25%
Immune Tolerance
25%
Lipocalin-2
25%
Immunocompromised Patient
25%
Pneumococcus
25%
Epidermal Growth Factor
25%
Tumor Vaccine
25%
Virus-Like Particle
25%
Cancer Growth Factor
25%
Lymphocyte
25%
Transforming Growth Factor Beta
25%
Isotope Labeling
25%
TLR4
25%
Birch
25%
Immunogenicity
25%
Immune Response
24%
Cetuximab
20%
Cancer Cell Line
18%
Antibodies
16%
Mediator
16%
Food Allergy
16%
Allergen Immunotherapy
16%
Epitope
16%
Serotype
12%
Medicine and Dentistry
Malignant Neoplasm
100%
Neoplasm
75%
Immunoglobulin E
75%
Immunotherapy
46%
Personalized Medicine
38%
Clinical Oncology
32%
Diseases
31%
Chemotherapy
29%
Oncology
28%
Retrospective Cohort Study
25%
Immunoglobulin G Antibody
25%
Diffuse Large B-Cell Lymphoma
25%
Fluorine-18
25%
Biliary Tract Cancer
25%
Xenograft
25%
Cancer Therapy
25%
In Vitro
25%
Pneumococcus
25%
Septic Shock
25%
Odds Ratio
25%
Colorectal Carcinoma
25%
Shock (Circulatory)
25%
Cancer Treatment
25%
Positron Emission Tomography
25%
Calreticulin
25%
Immunocompromised Patient
25%
Overall Survival
21%
International Prognostic Index
20%
Targeted Therapy
18%
Symptomatic Treatment
16%
Progression Free Survival
16%
Polyethylene Terephthalate
12%
Serotype
12%
Splenectomy
12%
Radioactive Tracer
12%
Infection
12%
Molecular Profiling
10%
Linear Regression Analysis
10%
Cyclophosphamide Plus Doxorubicin Plus Prednisolone Plus Rituximab Plus Vincristine
10%
Treatment Response
10%
Fibroblast Growth Factor Receptor 2
10%
Advanced Cancer
8%
Cancer of Unknown Primary
8%
Patient Referral
8%
Tumor-Related Gene
8%
Kaplan Meier Method
8%
Monoclonal Antibody
7%
Antibody-Drug Conjugate
6%
Antibody Therapy
6%
Radioimmunotherapy
6%
